Market capitalization | $3.32b |
Enterprise Value | $4.09b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 4.48 |
P/S ratio (TTM) P/S ratio | 3.64 |
P/B ratio (TTM) P/B ratio | 1.06 |
Revenue growth (TTM) Revenue growth | -0.75% |
Revenue (TTM) Revenue | $912.20m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
3 Analysts have issued a Neogen Corporation forecast:
3 Analysts have issued a Neogen Corporation forecast:
Aug '24 |
+/-
%
|
||
Revenue | 912 912 |
1%
1%
|
|
Gross Profit | 432 432 |
6%
6%
|
|
EBITDA | 177 177 |
9%
9%
|
EBIT (Operating Income) EBIT | 59 59 |
16%
16%
|
Net Profit | -24 -24 |
11%
11%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety, Animal Safety, and Corporate and Eliminations. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The Corporate and eliminations segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Head office | United States |
CEO | John Adent |
Employees | 2,917 |
Founded | 1981 |
Website | www.neogen.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.